Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 diabetes

Tourkmani AM 1 , Hassali MA 2 , Alharbi TJ 1 , Alkhashan HI 1 , Alobikan AH 1 , Bakhiet AH 1 Show all authors , Alqahtani HB 1 , Alrasheedy AA 3 , Alawwad AD 1 , Mishriky AM 1 , Aljadhey H 4

Affiliations 

  • 1 Family and Community Medicine Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
  • 2 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
  • 3 Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Qassim Saudi Arabia
  • 4 Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
Patient Prefer Adherence, 2016;10:1709-17.
PMID: 27660420 DOI: 10.2147/PPA.S113324

Abstract

Fasting during the month of Ramadan could lead to acute complications and increased hypoglycemic risk of patients with type 2 diabetes. Therefore, diabetes is one of the diseases that need careful observation and special considerations during Ramadan including patients' education and counseling.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications